| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/03/1999 | CA2218672A1 Antimicrobial agents for eucaryotic microorganisms and methods of growth suppression of eucaryotic microorganisms using these agents |
| 03/02/1999 | US5877342 Skin disorders; respiratory system disorders; cardiovascular disorders |
| 03/02/1999 | US5877321 Neurokinin receptor |
| 03/02/1999 | US5877317 Heterocyclic compounds for the treatment of CNS and cardiovascular disorders |
| 03/02/1999 | US5877316 Treatment of pain, inflammation, migraine and emesis. |
| 03/02/1999 | US5877313 Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP |
| 03/02/1999 | US5877309 Nucleotide sequences which suppress expression of jun n-terminal kinase oncogene by complementary hybridization; antiproliferative agents, antitumor agents, anticarcinogenic agentsand antimetastasis agents |
| 03/02/1999 | US5877308 Synthetic oligonucleotide that is complemtary to capl mrna including the 3' splice site thereby inhibiting capl gene expression; anticarcinogenic agents |
| 03/02/1999 | US5877302 Compacted nucleic acids and their delivery to cells |
| 03/02/1999 | US5877298 Acellular pertussis vaccines and methods of preparing thereof |
| 03/02/1999 | US5877296 Reacting disulfide analogs of calicheamicin family with a carrier such as protein, peptide, mono and polyclonal antibodies, their antigen-recognizing fragments and chemically or genetically engineered counterparts |
| 03/02/1999 | US5877274 Antimicrobial cationic peptides |
| 03/02/1999 | US5877223 Applying pulegone or piperitone. |
| 03/02/1999 | US5877221 Treating dementia |
| 03/02/1999 | US5877219 Non-steroidal ligands for the estrogen receptor |
| 03/02/1999 | US5877218 Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
| 03/02/1999 | US5877216 Treatment of female sexual dysfunction |
| 03/02/1999 | US5877215 Method of treating neoplastic cells with prostaglandin and radiation treatment or prostaglandin and platinum-based anti-tumor agents |
| 03/02/1999 | US5877213 Compositions and methods for therapy and prevention of cancer, AIDS, and anemia |
| 03/02/1999 | US5877212 Molecular complex and control-release of alpha hydroxyacids |
| 03/02/1999 | US5877211 Prostaglandins |
| 03/02/1999 | US5877210 Controlling immune response |
| 03/02/1999 | US5877209 The antioxidant or free radical blocking agent is ascorbic-acid, butylated hydroxytoluene (bht), butylated hydroxyanisole (bha), a mixture of ascorbic acid and bht or bha or a blend of tocopherols and ascorbic acid. |
| 03/02/1999 | US5877208 Naringin and naringenin as 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) reductase inhibitor |
| 03/02/1999 | US5877207 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/02/1999 | US5877206 Methods for inhibiting topoisomerase using procyanidin oligomers |
| 03/02/1999 | US5877205 Parenteral paclitaxel in a stable non-toxic formulation |
| 03/02/1999 | US5877204 Compounds containing a michael-acceptor, especially maleimide or maleic acid derivatives, directly or indirectly linked to a chromophore and their use in long lasting sunscreen compositions |
| 03/02/1999 | US5877203 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 03/02/1999 | US5877202 Indole derivatives useful to treat estrogen-related neoplasms and disorders |
| 03/02/1999 | US5877200 Cyclic amides |
| 03/02/1999 | US5877199 Heterocyclic compounds, their preparation and their therapeutic use |
| 03/02/1999 | US5877198 Treatment of urinary incontinence |
| 03/02/1999 | US5877196 N- 4-(imidazolyl or pyrazolyl)phenyl(oxy, sulfinyl, sulfenyl or sulfonyl)alkyl!carboxamides, sulfonamides or phosphoramides having antiarrhythmic properties |
| 03/02/1999 | US5877193 Use of N-(4-aryl-thiazol-2-yl)-sulfonamides |
| 03/02/1999 | US5877190 Substituted biphenyl compounds |
| 03/02/1999 | US5877189 Pure isomer |
| 03/02/1999 | US5877188 Psychological and behavioral disorders, antiemetics |
| 03/02/1999 | US5877187 Benzimidazole derivatives with antihistaminic activity |
| 03/02/1999 | US5877186 Carotenoid synthesis inhibiting herbicides and fatty acid synthesis inhibiting oxime herbicides as anti-apicomplexa protozoan parasite agents |
| 03/02/1999 | US5877185 Therapy for cancer or retrovirus |
| 03/02/1999 | US5877183 Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists |
| 03/02/1999 | US5877180 Method for treating inflammatory diseases with A2a adenosine receptor agonists |
| 03/02/1999 | US5877179 Cystic fibrosis |
| 03/02/1999 | US5877177 Carboxy piperidylacetamide tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 03/02/1999 | US5877176 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis |
| 03/02/1999 | US5877175 3-(pyrimidin-4-yl)-1-phenylpyridazin-4(1h)-ones, treatment of seizures and/or neurological disorders such as epilepsy and/or conditions in which there is neurological damage such as brain trauma, cerebral ischaemia, hemorrhage, head injuries and |
| 03/02/1999 | US5877173 Preventing neuronal degeneration in Alzheimer's disease |
| 03/02/1999 | US5877172 Process for isolating galanthamine |
| 03/02/1999 | US5877169 Methods of treatment of ischemic damage |
| 03/02/1999 | US5877168 Vitamin D derivative with substituent at the 2β-position |
| 03/02/1999 | US5877167 Method for inhibition of cell motility by sphingosine-1-phosphate and its derivatives |
| 03/02/1999 | US5877162 Short external guide sequences |
| 03/02/1999 | US5877158 Pro-prodrugs, their production and use |
| 03/02/1999 | US5877153 Heparin-binding peptides |
| 03/02/1999 | US5877120 Nicotinic acid derivatives and herbicides |
| 03/02/1999 | US5877022 Ribozymes targeted to APO(a) RNA |
| 03/02/1999 | US5876979 RNA component of mouse, rat, Chinese hamster and bovine telomerase |
| 03/02/1999 | US5876965 Nucleic acid encoding ARF-19, a novel regulator of the mammalian cell cycle |
| 03/02/1999 | US5876963 Human nucleotide pyrophosphohydrolase |
| 03/02/1999 | US5876931 Identification of genes |
| 03/02/1999 | US5876920 Screening for vircides and viral suppressors by contacting infected cell with agent, determining if suppression of prenylation of proteins; against hepatitis virus |
| 03/02/1999 | US5876916 Administration of glycerol-pyruvate or hydroxyacetone pyruvate ester with biocompatible carrier to mammals; as high calorie food, anticholesterol agents, antiishemic agents, organ preservative, antidiabetic agents |
| 03/02/1999 | US5876780 Feed containing betaine |
| 03/02/1999 | US5876763 Exercise preformance |
| 03/02/1999 | US5876760 Granules containing pranlukast, process for producing the granules, and method of improving adhesiveness of pranlukast |
| 03/02/1999 | US5876757 Magnesium taurine compound |
| 03/02/1999 | US5876756 Microcapsule containing amorphous water-soluble 2-piperazinone-1-acetic acid compound |
| 03/02/1999 | US5876751 Antispasmodic and antinflammatory composition and a process for the manufacture thereof |
| 03/02/1999 | US5876750 Dosage form comprises a laminated wall for maintaining the integrity of the dosage form and of the antiepileptic drug. |
| 03/02/1999 | US5876749 Pharmaceutical composition |
| 03/02/1999 | US5876746 Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
| 03/02/1999 | US5876737 Use of salicin as an anti-irritative active compound in cosmetic and topical dermatological preparations |
| 03/02/1999 | US5876729 Use of extracts of tamarind seeds rich in xyloglycans and cosmetic or pharmaceutical product containing such extracts |
| 03/02/1999 | US5876723 Purified human papillomavirus type 33 (HPV-33) peptides as an immunogenic composition |
| 03/02/1999 | US5876718 Using antibodies which bind to protein |
| 03/02/1999 | US5876709 Ophthalmic composition containing active Vitamin D |
| 03/02/1999 | US5876700 Inhalation |
| 03/02/1999 | US5876695 Nuclear magnetic resonance contrast agent |
| 03/02/1999 | US5876694 Azavesamicols |
| 03/02/1999 | US5876404 Spine distraction implant and method |
| 03/02/1999 | CA2242315A1 Mecb |
| 03/02/1999 | CA2242252A1 Dexb |
| 03/02/1999 | CA2241417A1 Novel ffh |
| 03/02/1999 | CA2175458C Novel benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 03/02/1999 | CA2175352C 3-aryl-4-alkyl and 4,5-dialkyl-4h-1,2,4-triazoles useful as memory enhancers |
| 03/02/1999 | CA2165419C Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents |
| 03/02/1999 | CA2117250C Alkoxyphenylalkylamine derivatives |
| 03/02/1999 | CA2062001C Stabilized pvp-i solutions |
| 03/02/1999 | CA1340417C Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same |
| 03/02/1999 | CA1340414C Inactivation of human immunodeficiency virus (hiv) in protein-containing solutions by phenols |
| 03/01/1999 | CA2242311A1 Novel compounds |
| 02/28/1999 | CA2246407A1 Use of inhibitors of the sodium-hydrogen exchanger for the production of a pharmaceutical for the treatment of disorders which are caused by protozoa |
| 02/28/1999 | CA2246224A1 Chroman derivative containing ophthalmic solution |
| 02/28/1999 | CA2246118A1 Substituted quinolone derivatives and pharmaceuticals containing the same |
| 02/28/1999 | CA2241427A1 Novel pyrr homolog |
| 02/28/1999 | CA2241424A1 Novel ftsy |
| 02/28/1999 | CA2241400A1 Ftsy |
| 02/27/1999 | CA2245776A1 Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and a medicament for the treatment of cardiovascular diseases |
| 02/27/1999 | CA2233681A1 Novel div1b |